Qureshi Abdul Rehman, Patel M, Neumark S, Wang L, Couban R J, Sadeghirad B, Bengizi A, Busse J W
College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.
Department of Health Research Methods, Evidence and Impact, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.
BMJ Mil Health. 2023 Dec 12. doi: 10.1136/military-2023-002554.
Chronic non-cancer pain is common among military veterans; however, the prevalence is uncertain. This information gap complicates policy decisions and resource planning to ensure veterans have access to healthcare services that align with their needs.
Following Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols, we searched MEDLINE, EMBASE, PsycINFO, CINAHL and Web of Science from inception to 9 February 2023 for observational studies reporting the prevalence of chronic non-cancer pain among military veterans. We performed random-effects meta-analysis to pool pain prevalence data across studies and used the Grading of Recommendations, Assessment, Development and Evaluation approach to evaluate the certainty of evidence.
Forty-two studies that included 14 305 129 veterans were eligible for review, of which 28 studies (n=5 011 634) contributed to our meta-analysis. Most studies (90%; 38 of 42) enrolled US veterans, the median of the mean age among study participants was 55 years (IQR 45-62) and 85% were male. The pooled prevalence of chronic non-cancer pain was 45%; however, we found evidence of a credible subgroup effect based on representativeness of the study population. Moderate certainty evidence found the prevalence of chronic pain among studies enrolling military veterans from the general population was 30% (95% CI 23% to 37%) compared with 51% (95% CI 38% to 64%) among military veterans sampled from populations with high rates of conditions associated with chronic pain (p=0.005).
We found moderate certainty evidence that 3 in every 10 military veterans from the general population live with chronic non-cancer pain. These findings underscore the importance of ensuring access to evidence-based care for chronic pain for veterans, and the need for prevention and early management to reduce transition from acute to chronic pain. Further research, employing a standardised assessment of chronic pain, is needed to disaggregate meaningful subgroups; for example, the proportion of veterans living with moderate to severe pain compared with mild pain.
慢性非癌性疼痛在退伍军人中很常见;然而,其患病率尚不确定。这一信息缺口使政策决策和资源规划变得复杂,难以确保退伍军人能够获得符合其需求的医疗服务。
按照系统评价与Meta分析方案的首选报告项目,我们检索了MEDLINE、EMBASE、PsycINFO、CINAHL和Web of Science数据库,从建库至2023年2月9日,查找报告退伍军人慢性非癌性疼痛患病率的观察性研究。我们进行随机效应Meta分析,汇总各研究的疼痛患病率数据,并采用推荐分级、评估、制定与评价方法评估证据的确定性。
42项研究纳入14305129名退伍军人,符合纳入标准,其中28项研究(n=5011634)纳入我们的Meta分析。大多数研究(90%;42项中的38项)纳入美国退伍军人,研究参与者的平均年龄中位数为55岁(四分位间距45 - 62岁),85%为男性。慢性非癌性疼痛的合并患病率为45%;然而,基于研究人群的代表性,我们发现了可信的亚组效应证据。中等确定性证据表明,从普通人群中招募的退伍军人慢性疼痛患病率为30%(95%CI 23%至37%),而从与慢性疼痛相关疾病高发病率人群中抽样的退伍军人患病率为51%(95%CI 38%至64%)(p=0.005)。
我们发现中等确定性证据表明,每10名普通人群中的退伍军人中有3人患有慢性非癌性疼痛。这些发现强调了确保退伍军人获得慢性疼痛循证护理的重要性,以及预防和早期管理以减少从急性疼痛转变为慢性疼痛的必要性。需要进一步开展采用慢性疼痛标准化评估的研究,以区分有意义的亚组;例如,与轻度疼痛相比,中度至重度疼痛的退伍军人比例。